Famous Fingers

So you don’t like doctors examining your prostate. . .?

Famous Fingers Collection

We know men feel uncomfortable at the thought of having their prostates checked by a doctor’s finger. So here’s the world’s first-ever exam gloves that replicate the fingers of famous people. Look out for these in your morning paper and hear about it on the radio.

This bold campaign to trigger a broader discussion about prostate cancer encourages men to talk to their doctor about personal risk and an early detection strategy that's right for them.

The good news is: digital rectal exams aren’t the only option. We urge men to start with a baseline PSA test.

Remember: many prostate cancers don’t present any symptoms, especially at an early stage. That’s where PSA testing is important.

When caught early, the survival rate for prostate cancer is close to 100%.
 

1. What is the PSA Test?

The PSA test is a simple blood test that measures the amount of prostate specific antigen (PSA) in your blood. A higher PSA level doesn’t always mean a man has prostate cancer, but it is an important indicator that something may be wrong and can spur on further investigation. Learn more.

2. How can the PSA test help?

Early detection of prostate cancer saves lives. When detected early, the survival rate for prostate cancer is close to 100%. Without testing, men are at a higher risk for diagnosis of more advanced and dangerous prostate cancer. Learn more.

3. What is the Digital Rectal Exam?

In a digital rectal exam (DRE), your doctor will feel the size and shape of the prostate by inserting a lubricated, gloved finger into the rectum. This test permits the doctor to feel the area where most prostate cancers are found. Learn more.


 
Help more men get tested
When detected early, survival for prostate cancer is close to 100%. We rely on the generosity of people like you to make sure that men know how important it is to get tested.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive